Haleon plc (HLN.L) Diversifiers

Equity · Currency in GBp · Last updated Jun 5, 2026

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

Looking to balance out your exposure to HLN.L? The ETFs below have the lowest correlation with HLN.L — they tend to move on their own, which can help reduce risk when HLN.L drops. The stock ideas table highlights individual companies that behave independently from HLN.L.

Best Diversifiers for HLN.L

0 ETFs have low correlation with HLN.L (below 0.3), 0 of which are negatively correlated. The least correlated is Vanguard FTSE 100 UCITS ETF Distributing (VUKE.L) (Europe Equities) with a 1Y correlation of 0.33, roughly unchanged from 0.33 over 3 years.

Symbol	Name	Correlation 1Y	Correlation 3Y	Correlation 5Y	Risk / Return Rank	Category	Compare
VUKE.L	Vanguard FTSE 100 UCITS ETF Distributing	0.33	0.33	—	56	Europe Equities	HLN.L vs VUKE.L

Diversification Analysis

Build a portfolio that complements HLN.L

Add HLN.L to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with HLN.L